BCG + Mitomycin trial for high-risk non-muscle-invasive bladder cancer: progress report and lessons learned

Dickon Hayne; Martin Stockler; Steve P. McCombie; Nicola Lawrence; Andrew Martin; Shomik Sengupta; Ian D. Davis

doi:10.1111/bju.13873

BCG + Mitomycin trial for high-risk non-muscle-invasive bladder cancer: progress report and lessons learned

Dickon Hayne, Martin Stockler, Steve P. McCombie, Nicola Lawrence, Andrew Martin, Shomik Sengupta, Ian D. Davis

UWA Medical School

Research output: Contribution to journal › Comment/debate › peer-review

1 Citation (Scopus)

299 Downloads (Pure)

Original language	English
Pages (from-to)	55-57
Number of pages	3
Journal	BJU International
Volume	119
Issue number	55
DOIs	https://doi.org/10.1111/bju.13873
Publication status	Published - 23 May 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/bju.13873

Hayne et al., 2017 The BCG + Mitomycin trialAccepted author manuscript, 133 KBLicence: CC BY-NC

Cite this

@article{2f05402bd77448c0ab0dcb21de2b173f,

title = "BCG + Mitomycin trial for high-risk non-muscle-invasive bladder cancer: progress report and lessons learned",

author = "Dickon Hayne and Martin Stockler and McCombie, {Steve P.} and Nicola Lawrence and Andrew Martin and Shomik Sengupta and Davis, {Ian D.}",

year = "2017",

month = may,

day = "23",

doi = "10.1111/bju.13873",

language = "English",

volume = "119",

pages = "55--57",

journal = "BJU International",

issn = "1464-4096",

publisher = "John Wiley & Sons",

number = "55",

}

TY - JOUR

T1 - BCG + Mitomycin trial for high-risk non-muscle-invasive bladder cancer

T2 - progress report and lessons learned

AU - Hayne, Dickon

AU - Stockler, Martin

AU - McCombie, Steve P.

AU - Lawrence, Nicola

AU - Martin, Andrew

AU - Sengupta, Shomik

AU - Davis, Ian D.

PY - 2017/5/23

Y1 - 2017/5/23

U2 - 10.1111/bju.13873

DO - 10.1111/bju.13873

M3 - Comment/debate

C2 - 28391606

SN - 1464-4096

VL - 119

SP - 55

EP - 57

JO - BJU International

JF - BJU International

IS - 55

ER -